GENB
Generate Biomedicines, Inc.
NASDAQ · Financial Services · Asset Management · US
$14.46
−8.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 118.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.07x
- Price / sales
- 58.18x
- Price / cash flow
- -9.25x
Enterprise value
- Enterprise value
- $1.5B
- EV / sales
- 45.80x
- EV / EBITDA
- -7.01x
- EV / EBIT
- -6.21x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026